80_FR_73996 80 FR 73769 - Agency Forms Undergoing Paperwork Reduction Act Review

80 FR 73769 - Agency Forms Undergoing Paperwork Reduction Act Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 227 (November 25, 2015)

Page Range73769-73770
FR Document2015-30061

Federal Register, Volume 80 Issue 227 (Wednesday, November 25, 2015)
[Federal Register Volume 80, Number 227 (Wednesday, November 25, 2015)]
[Notices]
[Pages 73769-73770]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-30061]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-15AUJ]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Paul Coverdell National Acute Stroke Program (PCNASP)--New--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Stroke is the fifth leading cause of death in the United States and 
results in approximately 130,000 deaths per year. Stroke outcomes 
depend upon the rapid recognition of signs and symptoms of stroke, 
prompt transport to a treatment facility, and early rehabilitation. 
Improving outcomes requires a coordinated systems approach involving 
pre-hospital care, emergency department and hospital care, 
rehabilitation, prevention of complications, and ongoing secondary 
prevention.
    Through the Paul Coverdell National Acute Stroke Program (PCNASP), 
CDC has been continuously working to measure and improve acute stroke 
care using well-known quality improvement strategies coupled with 
frequent evaluation of results. PCNASP awardees are state health 
departments who work with participating hospitals and EMS agencies in 
their jurisdictions to improve quality of care for stroke patients.
    Nine awardees were funded under five-year cooperative agreements 
effective July 1, 2015. Awardees and their selected hospital partners 
will systematically collect and report data on stroke care data across 
the continuum of care which includes pre-hospital (EMS), in-hospital, 
and post-hospital phases of care. In addition, PCNASP awardees will 
also request information from hospitals that admit and treat stroke 
patients in awardees' jurisdictions. This information is needed to 
understand the capacity and infrastructure of the systems for acute 
stroke care.
    Hospitals will transmit pre-hospital and post-hospital information 
to their awardee quarterly. The average burden per response is 15 
minutes for pre-hospital and post-hospital information transmission. 
There is no burden for hospitals to transmit in-hospital data, because 
awardees use their own processes to extract in-hospital data from 
hospitals' electronic systems. Each hospital will collect and transmit 
hospital inventory information to its PCNASP awardee annually. This 
average burden per response is 30 minutes.
    The average burden per response for awardees to transmit pre-
hospital, in-hospital, and post-hospital data to CDC will vary between 
30-90 minutes. The burden will be 30 minutes each for independent 
submission of information relating to the pre-hospital, in-hospital, 
and post-hospital phases of patient care. Alternatively, the burden 
will be 90 minutes for awardees who transmit pre-, in-, and post-
hospital data as one

[[Page 73770]]

combined file. CDC accepts file transmissions as individual phases or 
combined. In addition, each PCNASP awardee will prepare an annual 
aggregate hospital inventory file for transmission to CDC. The average 
burden of reporting hospital inventory information for each PCNASP 
awardee is eight hours per response.
    All patient, hospital, and EMS provider data that is submitted to 
CDC by PCNASP awardees will be de-identified and occur through secure 
data systems. Proposed data elements and quality indicators may be 
updated over time to include new or revised items based on evolving 
recommendations and standards in the field to improve the quality of 
stroke care.
    OMB approval is requested for three years. Participation is 
voluntary and there are no costs to respondents other than their time. 
The total estimated annualized burden hours are 382.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
PCNASP Hospital Partners..............  Pre-hospital quality of               78               4           15/60
                                         care data.
                                        Post-hospital quality of              20               4           15/60
                                         care data.
                                        Hospital inventory data.             315               1           30/60
PCNASP Awardee........................  Pre-hospital quality of                9               4           30/60
                                         care data.
                                        In-hospital quality of                 9               4           30/60
                                         care data.
                                        Post-hospital quality of               9               4           30/60
                                         care data.
                                        Hospital inventory data.               9               1               8
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-30061 Filed 11-24-15; 8:45 am]
BILLING CODE 4163-18-P



                                                                       Federal Register / Vol. 80, No. 227 / Wednesday, November 25, 2015 / Notices                                           73769

                                              support of DGHP country offices.                        DEPARTMENT OF HEALTH AND                              Background and Brief Description
                                              Specifically, it: (1) Coordinates all                   HUMAN SERVICES                                           Stroke is the fifth leading cause of
                                              DGHP procurement and extramural                                                                               death in the United States and results in
                                              activities in compliance with federal                   Centers for Disease Control and
                                                                                                                                                            approximately 130,000 deaths per year.
                                              appropriations law, congressional                       Prevention
                                                                                                                                                            Stroke outcomes depend upon the rapid
                                              intent, and global health policies; (2)                                                                       recognition of signs and symptoms of
                                              facilitates and manages the                             [30Day–16–15AUJ]
                                                                                                                                                            stroke, prompt transport to a treatment
                                              development, clearance, and award of                    Agency Forms Undergoing Paperwork                     facility, and early rehabilitation.
                                              all new and ongoing DGHP field grants,                  Reduction Act Review                                  Improving outcomes requires a
                                              cooperative agreements, and contracts;                                                                        coordinated systems approach involving
                                              (3) provides technical assistance and                      The Centers for Disease Control and                pre-hospital care, emergency
                                              guidance to country offices and DGHP                    Prevention (CDC) has submitted the                    department and hospital care,
                                              branches on budget and extramural                       following information collection request              rehabilitation, prevention of
                                              issues including assisting programs in                  to the Office of Management and Budget                complications, and ongoing secondary
                                              determining the appropriate funding                     (OMB) for review and approval in                      prevention.
                                              mechanism to support DGHP activities;                   accordance with the Paperwork                            Through the Paul Coverdell National
                                              (4) provides training and tools to DGHP                 Reduction Act of 1995. The notice for                 Acute Stroke Program (PCNASP), CDC
                                              country programs to improve budget                      the proposed information collection is                has been continuously working to
                                              and cooperative agreement                               published to obtain comments from the                 measure and improve acute stroke care
                                                                                                      public and affected agencies.                         using well-known quality improvement
                                              management; (5) manages DGHP
                                                                                                         Written comments and suggestions                   strategies coupled with frequent
                                              country budgets including conducting
                                                                                                      from the public and affected agencies                 evaluation of results. PCNASP awardees
                                              budget planning exercises, spend plan
                                                                                                      concerning the proposed collection of                 are state health departments who work
                                              development and reporting, annual                       information are encouraged. Your                      with participating hospitals and EMS
                                              close-out processes, and analyses to                    comments should address any of the                    agencies in their jurisdictions to
                                              inform country planning; (6) provides                   following: (a) Evaluate whether the                   improve quality of care for stroke
                                              funding and budgetary data for regular                  proposed collection of information is                 patients.
                                              reports including HHS and OMB                           necessary for the proper performance of                  Nine awardees were funded under
                                              reports, GAO and IG audits, country                     the functions of the agency, including                five-year cooperative agreements
                                              program reviews, and other requests for                 whether the information will have                     effective July 1, 2015. Awardees and
                                              data; (7) liaises and collaborates with                 practical utility; (b) Evaluate the                   their selected hospital partners will
                                              CDC financial and procurement-related                   accuracy of the agencies estimate of the              systematically collect and report data on
                                              units and offices including OFR and the                 burden of the proposed collection of                  stroke care data across the continuum of
                                              Information Technology Services Office;                 information, including the validity of                care which includes pre-hospital (EMS),
                                              (8) collaborates with other DGHP                        the methodology and assumptions used;                 in-hospital, and post-hospital phases of
                                              branches, other CDC and HHS programs                    (c) Enhance the quality, utility, and                 care. In addition, PCNASP awardees
                                              and offices, other USG agencies, and                    clarity of the information to be                      will also request information from
                                              other national and international                        collected; (d) Minimize the burden of                 hospitals that admit and treat stroke
                                              organizations on overseas management                    the collection of information on those                patients in awardees’ jurisdictions. This
                                              and operations priorities; (9) develops                 who are to respond, including through                 information is needed to understand the
                                              strategies to improve the technical skills              the use of appropriate automated,                     capacity and infrastructure of the
                                              and problem-solving abilities of country                electronic, mechanical, or other                      systems for acute stroke care.
                                              program managers and locally employed                   technological collection techniques or                   Hospitals will transmit pre-hospital
                                                                                                      other forms of information technology,                and post-hospital information to their
                                              staff who work in the budget and
                                                                                                      e.g., permitting electronic submission of             awardee quarterly. The average burden
                                              finance area; (10) provides short-term
                                                                                                      responses; and (e) Assess information                 per response is 15 minutes for pre-
                                              and long-term consultation and
                                                                                                      collection costs.                                     hospital and post-hospital information
                                              technical assistance for management                                                                           transmission. There is no burden for
                                                                                                         To request additional information on
                                              and operations issues to DGHP country                   the proposed project or to obtain a copy              hospitals to transmit in-hospital data,
                                              offices; (11) facilitates overseas                      of the information collection plan and                because awardees use their own
                                              purchasing and property management                      instruments, call (404) 639–7570 or                   processes to extract in-hospital data
                                              activities; (12) monitors risk                          send an email to omb@cdc.gov. Written                 from hospitals’ electronic systems. Each
                                              management of country operations and                    comments and/or suggestions regarding                 hospital will collect and transmit
                                              extramural awards; (13) oversees                        the items contained in this notice                    hospital inventory information to its
                                              property, facilities, motor pool, and                   should be directed to the Attention:                  PCNASP awardee annually. This
                                              records management; and (14)                            CDC Desk Officer, Office of Management                average burden per response is 30
                                              coordinates other logistics needs for                   and Budget, Washington, DC 20503 or                   minutes.
                                              DGHP overseas operations.                               by fax to (202) 395–5806. Written                        The average burden per response for
                                                                                                      comments should be received within 30                 awardees to transmit pre-hospital, in-
                                              James Seligman,
                                                                                                      days of this notice.                                  hospital, and post-hospital data to CDC
                                              Acting Chief Operating Officer, Centers for                                                                   will vary between 30–90 minutes. The
                                              Disease Control and Prevention.                         Proposed Project
tkelley on DSK3SPTVN1PROD with NOTICES




                                                                                                                                                            burden will be 30 minutes each for
                                              [FR Doc. 2015–29914 Filed 11–24–15; 8:45 am]              Paul Coverdell National Acute Stroke                independent submission of information
                                              BILLING CODE 4160–18–P                                  Program (PCNASP)—New—National                         relating to the pre-hospital, in-hospital,
                                                                                                      Center for Chronic Disease Prevention                 and post-hospital phases of patient care.
                                                                                                      and Health Promotion (NCCDPHP),                       Alternatively, the burden will be 90
                                                                                                      Centers for Disease Control and                       minutes for awardees who transmit
                                                                                                      Prevention (CDC).                                     pre-, in-, and post-hospital data as one


                                         VerDate Sep<11>2014   19:15 Nov 24, 2015   Jkt 238001   PO 00000   Frm 00072   Fmt 4703   Sfmt 4703   E:\FR\FM\25NON1.SGM   25NON1


                                              73770                      Federal Register / Vol. 80, No. 227 / Wednesday, November 25, 2015 / Notices

                                              combined file. CDC accepts file                              information for each PCNASP awardee                          based on evolving recommendations
                                              transmissions as individual phases or                        is eight hours per response.                                 and standards in the field to improve
                                              combined. In addition, each PCNASP                              All patient, hospital, and EMS                            the quality of stroke care.
                                              awardee will prepare an annual                               provider data that is submitted to CDC
                                                                                                                                                                          OMB approval is requested for three
                                              aggregate hospital inventory file for                        by PCNASP awardees will be de-
                                                                                                           identified and occur through secure data                     years. Participation is voluntary and
                                              transmission to CDC. The average                                                                                          there are no costs to respondents other
                                              burden of reporting hospital inventory                       systems. Proposed data elements and
                                                                                                           quality indicators may be updated over                       than their time. The total estimated
                                                                                                           time to include new or revised items                         annualized burden hours are 382.

                                                                                                          ESTIMATED ANNUALIZED BURDEN HOURS
                                                                                                                                                                                                        Average bur-
                                                                                                                                                                                        Number of re-
                                                                                                                                                                        Number of                        den per re-
                                                               Type of respondent                                              Form name                                                 sponses per
                                                                                                                                                                       respondents                          sponse
                                                                                                                                                                                          respondent      (in hours)

                                              PCNASP Hospital Partners ............................       Pre-hospital quality of care data ....................                78                  4          15/60
                                                                                                          Post-hospital quality of care data ..................                 20                  4          15/60
                                                                                                          Hospital inventory data ..................................           315                  1          30/60
                                              PCNASP Awardee ..........................................   Pre-hospital quality of care data ....................                 9                  4          30/60
                                                                                                          In-hospital quality of care data .......................               9                  4          30/60
                                                                                                          Post-hospital quality of care data ..................                  9                  4          30/60
                                                                                                          Hospital inventory data ..................................             9                  1              8



                                              Leroy A. Richardson,                                         and 325 mg/60 mg, if all other legal and                        A person may petition the Agency to
                                              Chief, Information Collection Review Office,                 regulatory requirements are met.                             determine, or the Agency may
                                              Office of Scientific Integrity, Office of the                FOR FURTHER INFORMATION CONTACT: Jane                        determine on its own initiative, whether
                                              Associate Director for Science, Office of the                Baluss, Center for Drug Evaluation and                       a listed drug was withdrawn from sale
                                              Director, Centers for Disease Control and                                                                                 for reasons of safety or effectiveness.
                                                                                                           Research, Food and Drug
                                              Prevention.
                                                                                                           Administration, 10903 New Hampshire                          This determination may be made at any
                                              [FR Doc. 2015–30061 Filed 11–24–15; 8:45 am]                                                                              time after the drug has been withdrawn
                                                                                                           Ave., Bldg. 51, Rm. 6278, Silver Spring,
                                              BILLING CODE 4163–18–P                                                                                                    from sale, but must be made prior to
                                                                                                           MD 20993–0002, 301–796–3469.
                                                                                                           SUPPLEMENTARY INFORMATION: In 1984,                          approving an ANDA that refers to the
                                                                                                           Congress enacted the Drug Price                              listed drug (§ 314.161 (21 CFR 314.161)).
                                              DEPARTMENT OF HEALTH AND                                                                                                  FDA may not approve an ANDA that
                                              HUMAN SERVICES                                               Competition and Patent Term
                                                                                                           Restoration Act of 1984 (Pub. L. 98–417)                     does not refer to a listed drug.
                                              Food and Drug Administration                                 (the 1984 amendments), which                                    TYLENOL WITH CODEINE
                                                                                                           authorized the approval of duplicate                         (acetaminophen with codeine
                                              [Docket No. FDA–2015–P–1153]                                 versions of drug products under an                           phosphate) oral tablets, 325 mg/7.5 mg,
                                              Determination That TYLENOL WITH                              ANDA procedure. ANDA applicants                              325 mg/15 mg, 325 mg/30 mg, and 325
                                              CODEINE (Acetaminophen With                                  must, with certain exceptions, show that                     mg/60 mg, are the subject of ANDA 85–
                                                                                                           the drug for which they are seeking                          056 held by McNeil Ortho
                                              Codeine Phosphate) Oral Tablets, 325
                                                                                                           approval contains the same active                            Pharmaceuticals, Inc., and were initially
                                              Milligrams/7.5 Milligrams, 325
                                                                                                           ingredient in the same strength and                          approved July 9, 1976. TYLENOL WITH
                                              Milligrams/15 Milligrams, 325
                                                                                                           dosage form as the ‘‘listed drug,’’ which                    CODEINE is indicated for the relief of
                                              Milligrams/30 Milligrams, and 325
                                                                                                           is a version of the drug that was                            mild to moderately severe pain.
                                              Milligrams/60 Milligrams, Were Not
                                                                                                           previously approved. ANDA applicants
                                              Withdrawn From Sale for Reasons of                                                                                           In a letter dated January 26, 1993,
                                                                                                           do not have to repeat the extensive
                                              Safety or Effectiveness                                                                                                   McNeil Ortho Pharmaceuticals, Inc.
                                                                                                           clinical testing otherwise necessary to
                                                                                                                                                                        notified FDA that TYLENOL WITH
                                              AGENCY:     Food and Drug Administration,                    gain approval of a new drug application
                                                                                                                                                                        CODEINE (acetaminophen with codeine
                                              HHS.                                                         (NDA).
                                                                                                              The 1984 amendments include what                          phosphate) oral tablets, 325 mg/7.5 mg,
                                              ACTION:    Notice.                                                                                                        325 mg/15 mg, 325 mg/30 mg, and 325
                                                                                                           is now section 505(j)(7) of the Federal
                                              SUMMARY:   The Food and Drug                                 Food, Drug, and Cosmetic Act (21 U.S.C.                      mg/60 mg, were being discontinued,
                                              Administration (FDA or Agency) has                           355(j)(7)), which requires FDA to                            and FDA moved the drug product to the
                                              determined that TYLENOL WITH                                 publish a list of all approved drugs.                        ‘‘Discontinued Drug Product List’’
                                              CODEINE (acetaminophen with codeine                          FDA publishes this list as part of the                       section of the Orange Book.
                                              phosphate) oral tablets, 325 milligrams                      ‘‘Approved Drug Products With                                   Lachman Consultant Services, Inc.
                                              (mg)/7.5 mg, 325 mg/15 mg, 325 mg/30                         Therapeutic Equivalence Evaluations,’’                       submitted a citizen petition dated April
                                              mg, and 325 mg/60 mg, were not                               which is known generally as the                              7, 2015 (Docket No. FDA–2015–P–
                                              withdrawn from sale for reasons of                           ‘‘Orange Book.’’ Under FDA regulations,                      1153), under 21 CFR 10.30, requesting
tkelley on DSK3SPTVN1PROD with NOTICES




                                              safety or effectiveness. This                                drugs are removed from the list if the                       that the Agency determine whether
                                              determination will allow FDA to                              Agency withdraws or suspends                                 TYLENOL WITH CODEINE
                                              approve abbreviated new drug                                 approval of the drug’s NDA or ANDA                           (acetaminophen with codeine
                                              applications (ANDAs) for TYLENOL                             for reasons of safety or effectiveness or                    phosphate) oral tablets, 325 mg/7.5 mg,
                                              WITH CODEINE (acetaminophen with                             if FDA determines that the listed drug                       325 mg/15 mg, 325 mg/30 mg, and 325
                                              codeine phosphate) oral tablets, 325 mg/                     was withdrawn from sale for reasons of                       mg/60 mg, were withdrawn from sale
                                              7.5 mg, 325 mg/15 mg, 325 mg/30 mg,                          safety or effectiveness (21 CFR 314.162).                    for reasons of safety or effectiveness.


                                         VerDate Sep<11>2014     19:15 Nov 24, 2015    Jkt 238001   PO 00000     Frm 00073     Fmt 4703    Sfmt 4703    E:\FR\FM\25NON1.SGM    25NON1



Document Created: 2018-03-01 11:15:13
Document Modified: 2018-03-01 11:15:13
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation80 FR 73769 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR